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An antiserum raised to the extracellular domain (residues 556-566) of the Alzheimer amyloid precursor protein recognized 70 and 88 kDa proteins 
m Western blots of rat, Alzheimer, Down’s syndrome and control human brain separated by SDS-PAGE. The 70 kDa protein band was resolved 
into 5 spots by two-dimensional electrophoresis. The findings provide further evidence that a 70 kDa protein is a metabohte of the amyloid precursor 
protem and reveal an 88 kDa protein which was reduced in 3 out of 6 brains with Alzheimer pathology. 
Amyloid precursor antiserum; Gel electrophoresis; Western blotting; Alzhetmer-type dementia; Down’s syndrome 
1. INTRODUCTION 
Amyloid, an aggregate of a 42-43 amino acid pep- 
tide [l], is deposited in brain plaques and blood vessels 
in ATD and Down’s syndrome. A search for possible 
metabolites of the amyloid precursor protein (proA4) 
revealed a soluble protein of approximately 70 kDa in 
human and rat brain which was recognized by an an- 
tiserum raised to the C-terminus of proA (anti-C) [2]. 
In this study, we provide further evidence that the 
70 kDa protein is related to proA and describe an 
88 kDa protein also recognized by an antiserum raised 
to the putative extracellular domain of proA (anti-E). 
were centrifuged at 14000 x g for 18 min, and the supernatant and 
pellet fractions prepared for SDS-PAGE by boiling for 5 min in the 
presence of 2% SDS and 5% 2-mercaptoethanol. A supernatant frac- 
tion from rat PC12 pheochromocytoma cells was similarly prepared 
following incubation of the cells for 30 min at 0°C with 2% Triton 
X-100 and centrifugation at 14000 x g for 10 min. 
2.3. SDS-PAGE, Western blotting and immunostaining 
Samples containing 2.05-3.40 pg protein were applied to JO-15% 
micro-gradient gels and SDS-PAGE performed on a PhastSystem ap- 
paratus (Pharmacia Ltd). The separated proteins were transferred to 
polyvinylidene difluoride membranes (Immobilon, Millipore Ltd) by 
diffusion at 7O’C on the PhastSystem. Immunostaining of blotted 
proteins with anti-E and anti-C was performed [2] with 1: 1200 
(fig.la,b) or 1 :2000 (fig.lc-o, fig.2) dilutions of the antisera. The 
specificity of staining was examined with antiserum containing an- 
tigen peptide (300 pg/ml antiserum). 
2. EXPERIMENTAL 2.4. 2-D gel electrophoresis 
2.1. Production of antiserum to the extracellular domain of proA 
The peptide HrN-CANTENEVEPVD-COOH, consisting of a 
regton just extracellular to the transmembrane domain of proA 
(residues 556-566 in [I]) with an N-terminal cysteine to permit con- 
jugation to thyroglobulin, was synthesized and an antiserum (anti-E) 
raised in rabbits as described previously [2]. 
2.2. Preparation of tissue samples for SDS-PAGE 
Frozen human autopsy tissues and fresh rat brain, cerebral cortex 
and hypothalamus were prepared with slight modifications to the 
methods described previously [2]. Tissue homogenates in Tris buffer 
A supernatant fraction prepared in 1 mM EDTA, 10 mM Tris- 
HCl, pH 7.5, from frontal cortex of a control case (65 years) was 
diluted in buffer containing 9.5 M urea and 2% Nonidet P40, and 
5Opg sample protein subjected to 2-D electrophoresis using a 
modified O’Farrell technique [3]. The first-dimension gel contained 
2% Pharmalytes (pH 4-6.5:pH 3-10, 4: 1; Pharmacia Ltd). The se- 
cond dimension was run on precast gradient minigels (type PAA 
4/30, Pharmacia Ltd) and was followed by electrophoretic transfer 
[2] of the separated proteins to Immobilon. 
3. RESULTS 
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The antiserum raised to the extracellular domain of 
proA (anti-E) bound to several proteins on Western 
blots of human cerebral cortex separated by SDS- 
PAGE. Only two of these proteins (approximately 70 
and 88 kDa) were stained specifically in that they were 
not stained by antiserum blocked by preincubation with 
the antigen peptide (fig.la,b). The 70 kDa protein was 
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Fig.1. Western blots of various tissue samples eparated by SDS-PAGE and immunostained with anti-E. All samples were 14000 x g supernatants 
of tissue homogenates, as in section 2.2, except for (f) and (j). (a) Human frontal cortex; (b) as (a) but with blocked antiserum; (c) rat midbrain; 
(d) human cerebellum; (e) human corpus callosum; (f) human temporal cortex: particulate fraction; (g) human liver; (h) human kidney; (i) human 
skeletal muscle; (j) PC12 cells: Triton X-100 soluble fraction; (k) ATD temporal cortex: 80 years; (1) control temporal cortex: 80 years; (m) Down’s 
temporal cortex: 1.5 years; (n) Down’s temporal cortex: 63 years; (0) ATD temporal cortex: 88 years. 
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Fig.2. 2-D blot of human frontal cortex immunostained with anti-C and (insert) anti-E. (a) Unblocked antisera; (b) antisera blocked with the 
appropriate proA peptide. The major spots in (a) and the insert are identical. 
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occasionally resolved into a closely-spaced doublet 
band when stained with anti-E (e.g. fig.ln), whereas a 
single band was always observed with anti-C [2]. 
When visualized with anti-C, the 70 kDa protein was 
confined largely to the Tris buffer-soluble fraction of 
brain tissue, and little staining was observed in the solu- 
ble or particulate fractions of peripheral tissues [2]. A 
similar distribution was observed for the 70 and 88 kDa 
proteins visualised with anti-E. The supernatant frac- 
tions of rat cerebral cortex, hypothalamus and mid- 
brain, and human frontal cortex, temporal cortex, 
cerebellum and corpus callosum showed marked im- 
munoreactivity, whereas the SDS-extracted particulate 
fractions showed weak immunoreactivity (fig. la,c-f,l). 
Human liver, kidney and skeletal muscle contained a 
little 70 kDa protein but no detectable 88 kDa protein 
(fig.lg-i). An extract of cultured rat PC12 cells con- 
tained 70 and 88 kDa proteins (fig.lj). 
by anti-E. These proteins may arise through post- 
translational modifications (e.g. glycosylation, 
phosphorylation) of a single proA4-related protein. 
The 88 kDa protein recognized by anti-E was reduced 
in some cases with Alzheimer pathology but did not ap- 
pear in 2-D gels, possibly because its pZ was outside the 
range of our gel system or because its antibody binding 
site was sensitive to the conditions used in the first 
dimension. 
Blots of temporal cortex from 6 controls (1.2 years 
and 65-82 years) and 2 young cases of Down’s syn- 
drome (1.5 and 27 years) stained with anti-E showed 
similar 70 and 88 kDa immunoreactivity (fig.ll,m). 
Comparison of blots from 5 ATD cases (65-88 years) 
and one Down’s case with brain plaques and tangles (62 
years) with blots from the 5 elderly controls showed no 
difference in the 70 kDa protein but a reduced staining 
of the 88 kDa protein in 2 ATD cases (65 and 88 years) 
and the Down’s case (fig.lk,l,n,o). 
Other workers [4,5] have confirmed our finding [2] 
that a soluble brain protein of approximately 70 kDa 
can be detected with antisera to the C-terminal pen- 
tadecapeptide of proA4, and Kametani et al. [4] suggest 
that this protein may be the final intermediate in the 
process of amyloid formation. By contrast, 
Weidemann et al. [6] suggest hat proA is cleaved to 
an extracellular N-terminal 91 kDa protein (which may 
resemble our 88 kDa protein) and a transmembrane 
17-18 kDa C-terminal protein from which amyloid is 
formed. It is possible that more than one metabolic 
pathway is involved in the processing of proA4, and an 
imbalance between pathways may lead to amyloid 
deposition. 
In blots of 2-D gels of human cerebral cortex in- 
cubated with anti-E, the 70 kDa staining was resolved 
into 2 spots in the pZ 6.2 region (measured with a sur- 
face microelectrode) but the 88 kDa protein was not 
observed. With anti-C, the staining at 70 kDa could be 
resolved into 5 spots (fig.2). These spots appeared to 
represent relatively abundant tissue proteins as judged 
by Coomassie blue staining. 
In conclusion, we have identified 2 proteins of 70 and 
88 kDa which are probable metabolites of the amyloid 
precursor protein, and which may be involved in 
amyloid deposition in ATD and Down’s syndrome. 
Resolution of these proteins by 2-D gels and the use of 
(PC12) cells in culture are valuable tools which may 
allow elucidation of the metabolism of proA and 
ultimately the mechanism of amyloid deposition. 
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4. DISCUSSION REFERENCES 
Previously [2], we suggested that the 70 kDa brain 
protein recognized by anti-C, our antiserum to the C- 
terminus of proA4, could be a proA4-related protein or 
a protein unrelated to the amyloid precursor but con- 
taining an epitope found in proA4. The present results 
make it much more likely that the 70 kDa protein is in- 
deed related to proA since a 70 kDa protein was also 
recognized by an antiserum (anti-E) raised to another 
region of proA4. The 70 kDa protein band stained by 
anti-C in SDS-PAGE gels consists of at least 5 proteins 
with slightly different pls, two of which are recognized 
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